Explore 3 Stock Ideas & Industry Insights Download Free Report
Kooth PLC (LSE: KOO), the AIM-quoted digital mental health provider, is shrinking at the top line while becoming markedly more profitable underneath. Its half-year trading update on 29 July 2026 guided to adjusted EBITDA of £5.0m to £5.4m for the six months to 30 …
NIOX Group Plc (LSE: NIOX) came within a whisker of leaving the London market last year. Keensight Capital's indicative 81p-a-share approach in March 2025 won a "minded to recommend" from the board, only for the private equity firm to walk away in April citing …
The question is whether the pipeline can deliver a catalyst big enough to change the narrative before the next cheque is needed. Solvonis has a Phase 3 asset in severe alcohol use disorder, a US programme approaching an IND filing and a discovery compound …
Six months ago Oxford Biomedica plc (LSE: OXB) was the subject of a private-equity approach; today it is a FTSE 250 cell and gene therapy manufacturer digesting a guidance cut and preparing to publish half-year results on 22 September 2026. A walked-away bidder, a …
Renalytix Plc (LSE:RENX) has spent two years shrinking, refinancing and rebuilding after its Nasdaq exit, largely out of the spotlight. On 1 September 2026 the AI-enabled kidney diagnostics group gave the market two reasons to look again: a multi-year collaboration with Quest Diagnostics, one …
Against that backdrop, Futura has won European clearance for a faster-acting version, Eroxon Intense, reported encouraging user data for its female sexual health gel WSD4000, and handed off US distribution to a new partner. With aMarket Valueof barely £2m, the pressing question is whether …
Inspiration Healthcare Group Plc — LSE:IHC closed 2.05% higher on03 September 2026, with the shares at 19.39p after a gain of 0.39p on the day.
Ondine Biomedical Inc. — LSE:OBI closed unchanged on03 September 2026, with the shares at 11.50p and no net movement on the day.
TheraCryf Plc — LSE:TCF closed 5.05% lower on03 September 2026, with the shares at 0.1804p after a decline of 0.0096p on the day.
Fusion Antibodies Plc — LSE:FAB closed 1.66% higher on03 September 2026, with the shares at 12.20p after a gain of 0.20p on the day.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…